Boston Scientific CorporationBSXNYSE
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
28.21%
↑ 42% above average
Average (39q)
19.84%
Historical baseline
Range
High:529.51%
Low:-213.99%
CAGR
+2.9%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 28.21% |
| Q2 2025 | -8.59% |
| Q1 2025 | 52.12% |
| Q4 2024 | -12.61% |
| Q3 2024 | -9.77% |
| Q2 2024 | 15.99% |
| Q1 2024 | 15.41% |
| Q4 2023 | 0.00% |
| Q3 2023 | 1.27% |
| Q2 2023 | 6.99% |
| Q1 2023 | 14.70% |
| Q4 2022 | -2.39% |
| Q3 2022 | -3.56% |
| Q2 2022 | 4.38% |
| Q1 2022 | 0.00% |
| Q4 2021 | 3.39% |
| Q3 2021 | -13.50% |
| Q2 2021 | 41.94% |
| Q1 2021 | 106.90% |
| Q4 2020 | -33.59% |
| Q3 2020 | 529.51% |
| Q2 2020 | -127.35% |
| Q1 2020 | -45.48% |
| Q4 2019 | 3.02% |
| Q3 2019 | -7.89% |
| Q2 2019 | 0.47% |
| Q1 2019 | 1.18% |
| Q4 2018 | 3.16% |
| Q3 2018 | -8.05% |
| Q2 2018 | -2.19% |
| Q1 2018 | 2.93% |
| Q4 2017 | 18.09% |
| Q3 2017 | -4.81% |
| Q2 2017 | 28.25% |
| Q1 2017 | -3.14% |
| Q4 2016 | -5.36% |
| Q3 2016 | 200.60% |
| Q2 2016 | -213.99% |
| Q1 2016 | 208.12% |
| Q4 2015 | 9.36% |